Through a recent five-year, $2.3 million grant from the National Institutes of Health (NIH), University of Kentucky faculty Don Frazier and Brett Spear will partner with faculty from qualified minority-serving institutions across the U.S. and Puerto Rico to help improve diversity in science and health care. 

190213DONFRAZIER12 copy.JPG
190213DONFRAZIER12 copy.JPG

Stay up to date on this event by visiting its page here.

SAVE THE DATE
May 22, 2019 at the Bill Gatton Student Center 

More details to follow about:
Registration
Agenda
Research Blitz
Poster Session

PGY R&E Day on blue with yellow-01.jpg
PGY R&E Day on blue with yellow-01.jpg

"The American Journal of Public Health special issue New Perspectives to Advance Minority Health and Health Disparities Research is the culmination of a 2-year NIMHD-led transdisciplinary science visioning process that bridged scientific disciplines to develop a coordinated research vision.

ajph.2019.109.issue-s1.cover__0.jpg
ajph.2019.109.issue-s1.cover__0.jpg

Abstract 

Heparin-binding EGF-like growth factor (HB-EGF) is a representative EGF family member that interacts with EGFR under diverse stress environment. Previously, we reported that the HB-EGF-targeting using antisense oligonucleotide (ASO) effectively suppressed an aortic aneurysm in the vessel wall and circulatory lipid levels. In this study, we further examined the effects of the HB-EGF ASO administration on the development of hyperlipidemia-associated atherosclerosis using an atherogenic mouse model.

METHODS AND RESULTS:

Article Image 2-18-19.PNG
Article Image 2-18-19.PNG

A meeting in early 2010 sparked Dr. Ima Ebong's passion to advocate for greater minority representation in medical school — a passion that has propelled her to national recognition for her work.

Ebong with patient.JPG
Ebong with patient.JPG

Abstract

Dioxin like PCB image.PNG
Dioxin like PCB image.PNG

This month, our department published the following 6 publications!

IMG_0345.jpg
IMG_0345.jpg

As a longtime pathologist at the University of Kentucky, Dr. Charles Lutz is no stranger to cancer.

Lutz has spent much of his career in the lab, helping patients behind the scenes. At the UK Markey Cancer Center, he works in molecular diagnosis and HLA tissue typing in bone marrow transplantation for leukemia and other cancers. He also helps match patients in end-stage organ failure with an appropriate solid organ transplant for the UK Transplant Center.

lutz_profile_picture.jpg
lutz_profile_picture.jpg
J Clin Invest. 2019 Feb 1;129(2):496-498. doi: 10.1172/JCI125958.
Research.jpg
Research.jpg

As a raft of new treatments for HIV infection have come on the market in the past 20 years, AIDS patients have gotten access to drugs that allow them to live longer.

"These drugs are miracles," said Dr. Richard N. Greenberg, an infectious disease specialist at the University of Kentucky. "Before the advent of anti-retroviral drugs, HIV infection was a death sentence. Now, taken properly, the life span of a person with an HIV infection is practically normal."

HIV virus.jpg
HIV virus.jpg